Assenagon Asset Management S.A. Has $26.17 Million Stake in Alignment Healthcare, Inc. $ALHC

Key Points

• Assenagon Asset Management S.A. increased its stake in Alignment Healthcare by 124.8%, owning nearly 1.87 million shares valued at approximately $26.17 million.
• Insider transactions revealed significant stock sales, with CEO John E. Kao selling over 355,000 shares for about $5.83 million, indicating a 7.26% decrease in his position.
• Alignment Healthcare reported a 49% increase in revenue year-over-year for the last quarter, with earnings per share beating estimates at $0.07.

Assenagon Asset Management S.A. increased its position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 124.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,869,035 shares of the company's stock after acquiring an additional 1,037,638 shares during the quarter. Assenagon Asset Management S.A. owned about 0.94% of Alignment Healthcare worth $26,166,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in ALHC. Vanguard Group Inc. increased its position in shares of Alignment Healthcare by 13.2% during the first quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company's stock worth $206,941,000 after acquiring an additional 1,295,825 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its position in shares of Alignment Healthcare by 5.0% in the first quarter. T. Rowe Price Investment Management Inc. now owns 9,078,113 shares of the company's stock worth $169,035,000 after purchasing an additional 429,071 shares in the last quarter. Wellington Management Group LLP lifted its position in shares of Alignment Healthcare by 0.9% in the first quarter. Wellington Management Group LLP now owns 7,509,057 shares of the company's stock worth $139,819,000 after purchasing an additional 70,557 shares in the last quarter. 8 Knots Management LLC lifted its position in shares of Alignment Healthcare by 28.9% in the first quarter. 8 Knots Management LLC now owns 4,715,472 shares of the company's stock worth $87,802,000 after purchasing an additional 1,056,777 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its position in shares of Alignment Healthcare by 9.7% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,199,421 shares of the company's stock worth $40,954,000 after purchasing an additional 193,644 shares in the last quarter. Institutional investors and hedge funds own 86.19% of the company's stock.

Insider Buying and Selling

In other news, insider Robert L. Scavo sold 29,535 shares of the business's stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total value of $484,669.35. Following the completion of the sale, the insider owned 572,555 shares of the company's stock, valued at approximately $9,395,627.55. The trade was a 4.91% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Atlantic (Aln Hlth) L. General sold 6,246,096 shares of the business's stock in a transaction dated Wednesday, September 17th. The shares were sold at an average price of $16.01, for a total transaction of $99,999,996.96. Following the completion of the sale, the director directly owned 24,596,079 shares of the company's stock, valued at approximately $393,783,224.79. The trade was a 20.25% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 7,388,173 shares of company stock valued at $118,068,256 in the last 90 days. 6.60% of the stock is currently owned by corporate insiders.

Alignment Healthcare Stock Performance

Shares of NASDAQ:ALHC traded up $0.55 on Monday, hitting $17.09. The company had a trading volume of 2,329,627 shares, compared to its average volume of 4,276,943. Alignment Healthcare, Inc. has a 1-year low of $9.15 and a 1-year high of $21.06. The stock has a market cap of $3.38 billion, a price-to-earnings ratio of -61.03 and a beta of 1.17. The stock has a 50 day moving average price of $14.78 and a 200 day moving average price of $15.59. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.14. The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $960.25 million. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. Alignment Healthcare's quarterly revenue was up 49.0% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.13) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have recently commented on ALHC. Stephens raised shares of Alignment Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Zacks Research raised shares of Alignment Healthcare to a "hold" rating in a research report on Friday, August 8th. KeyCorp raised shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price objective on the stock in a research report on Monday, August 25th. Wall Street Zen downgraded shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, August 10th. Finally, Barclays upgraded shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and boosted their target price for the stock from $9.00 to $13.00 in a report on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, Alignment Healthcare currently has an average rating of "Moderate Buy" and an average target price of $18.83.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.